US Patent 10941142 Formulations of a compound modulating kinases
Patent 10941142 was granted and assigned to Plexxikon Inc. on March, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 12, 2019
0
Date of Patent
March 9, 2021
0
Patent Application Number
16510764
0
Patent Inventor Names
Tomoari Kamo
0
Gary Conard Visor
0
Hamid Rezaei
0
Hiroshi Yamakose
0
Prabha N. Ibrahim
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10941142 Formulations of a compound modulating kinases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
